Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Gene Therapy|February 17, 2010
Engineered E. coli as vehicles for targeted therapeuticsCaitlin Buttaro, Johannes H Fruehauf
Idrugs : the Investigational Drugs Journal|September 30, 2010
Bacterial vectors and delivery systems in cancer therapyRoman Gardlik, Johannes H Fruehauf
Therapeutic Delivery|July 25, 2012
Delivery of therapeutic RNA molecules to cancer cells by bacteriaHermann Lage, Johannes H Fruehauf
Methods in Molecular Biology (Clifton, N.J.)|December 3, 2008
Transkingdom RNA interference (tkRNAi): a novel method to induce therapeutic gene silencingThu A Nguyen, Johannes H Fruehauf
Cell Cycle (Georgetown, Tex.)|September 23, 2009
Delivery of short hairpin RNAs by transkingdom RNA interference modulates the classical ABCB1-mediated multidrug-resistant phenotype of cancer cellsAndrea Krühn, Aijin Wang, Johannes H Fruehauf, et al.
Current Opinion in Molecular Therapeutics|April 4, 2008
RNAi therapeutics: an update on deliveryThu Nguyen, Ellen M Menocal, Jens Harborth, et al.
Pharmacogenomics|February 5, 2008
Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeuticsAndrew C Keates, Johannes H Fruehauf, Shuanglin Xiang, et al.
Cell Cycle (Georgetown, Tex.)|August 31, 2006
Delivery of RNA interferenceCharles X Li, Amy Parker, Ellen Menocal, et al.
Archives of Gynecology and Obstetrics|September 8, 2007
High-intensity focused ultrasound for the targeted destruction of uterine tissues: experiences from a pilot study using a mobile HIFU unitJohannes H Fruehauf, Walter Back, Alexa Eiermann, et al.
Blood|November 20, 2008
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingMarc S Raab, Iris Breitkreutz, Giovanni Tonon, et al.
Pageof 1